QUEBEC CITY, Oct. 29, 2013 /PRNewswire/ - Aeterna Zentaris
Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will
announce its third quarter 2013 financial and operating results
after market close on Tuesday, November 5,
2013. The Company will host a conference call to discuss
these results on Wednesday, November 6,
2013, at 8:30 a.m., Eastern
Time.
Participants may access the live webcast via the Company's
website at www.aezsinc.com in the "Newsroom" section, or by
telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside
Canada, 888-231-8191. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing novel treatments in oncology and
endocrinology. The Company's pipeline encompasses compounds from
drug discovery to regulatory approval. For more information, visit
www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.